The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients

Table 2 The results of hazard ratio values for each protein in General cohort

Protein	Hazard Ratio	95% Confidence Interval	p value
NFKB1	0.69	0.58–0.82	< 0.001
STAT3	1.00	0.82–1.22	0.994
CTSG	1.47	1.26–1.71	< 0.001
TGFB1	1.49	1.23–1.81	< 0.001
SNRPD2	0.60	0.52–0.70	< 0.001
TAP1	0.64	0.55–0.74	< 0.001
PDCD1	0.61	0.51–0.72	< 0.001

ISSN: 1471-2407